Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 4
1952 2
1953 1
1954 6
1955 12
1956 6
1957 3
1958 23
1959 13
1960 9
1961 14
1962 16
1963 24
1964 18
1965 28
1966 33
1967 32
1968 35
1969 42
1970 43
1971 61
1972 50
1973 49
1974 48
1975 48
1976 48
1977 71
1978 59
1979 77
1980 75
1981 67
1982 89
1983 78
1984 81
1985 78
1986 105
1987 110
1988 123
1989 134
1990 121
1991 121
1992 142
1993 133
1994 124
1995 118
1996 131
1997 171
1998 159
1999 173
2000 227
2001 238
2002 213
2003 257
2004 270
2005 294
2006 294
2007 314
2008 319
2009 371
2010 383
2011 439
2012 440
2013 459
2014 423
2015 455
2016 453
2017 453
2018 473
2019 460
2020 509
2021 537
2022 51
Text availability
Article attribute
Article type
Publication date

Search Results

10,559 results
Results by year
Filters applied: . Clear all
Page 1
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, Jerby-Arnon L, Chanoch-Myers R, Hara T, Richman AR, Ito Y, Pyrdol J, Friedrich M, Schumann K, Poitras MJ, Gokhale PC, Gonzalez Castro LN, Shore ME, Hebert CM, Shaw B, Cahill HL, Drummond M, Zhang W, Olawoyin O, Wakimoto H, Rozenblatt-Rosen O, Brastianos PK, Liu XS, Jones PS, Cahill DP, Frosch MP, Louis DN, Freeman GJ, Ligon KL, Marson A, Chiocca EA, Reardon DA, Regev A, Suvà ML, Wucherpfennig KW. Mathewson ND, et al. Among authors: ito y. Cell. 2021 Mar 4;184(5):1281-1298.e26. doi: 10.1016/j.cell.2021.01.022. Epub 2021 Feb 15. Cell. 2021. PMID: 33592174 Free PMC article.
Whole-genome landscape of adult T-cell leukemia/lymphoma.
Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah UA, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K. Kogure Y, et al. Among authors: ito y. Blood. 2021 Oct 25:blood.2021013568. doi: 10.1182/blood.2021013568. Online ahead of print. Blood. 2021. PMID: 34695199
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.
Kumar S, Zeng Z, Bagati A, Tay RE, Sanz LA, Hartono SR, Ito Y, Abderazzaq F, Hatchi E, Jiang P, Cartwright ANR, Olawoyin O, Mathewson ND, Pyrdol JW, Li MZ, Doench JG, Booker MA, Tolstorukov MY, Elledge SJ, Chédin F, Liu XS, Wucherpfennig KW. Kumar S, et al. Among authors: ito y. Cancer Discov. 2021 Aug;11(8):2050-2071. doi: 10.1158/2159-8290.CD-20-1144. Epub 2021 Mar 11. Cancer Discov. 2021. PMID: 33707234 Free article.
N6-methyladenosine (m6A) is an endogenous A3 adenosine receptor ligand.
Ogawa A, Nagiri C, Shihoya W, Inoue A, Kawakami K, Hiratsuka S, Aoki J, Ito Y, Suzuki T, Suzuki T, Inoue T, Nureki O, Tanihara H, Tomizawa K, Wei FY. Ogawa A, et al. Among authors: ito y. Mol Cell. 2021 Feb 18;81(4):659-674.e7. doi: 10.1016/j.molcel.2020.12.038. Epub 2021 Jan 19. Mol Cell. 2021. PMID: 33472058
Reply.
Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, Ito Y, Terasaki H. Fujita A, et al. Among authors: ito y. Retina. 2021 Sep 1;41(9):e54. doi: 10.1097/IAE.0000000000003173. Retina. 2021. PMID: 33814538 No abstract available.
Randomized Controlled Trial of High-Flow Nasal Cannula in Preterm Infants After Extubation.
Uchiyama A, Okazaki K, Kondo M, Oka S, Motojima Y, Namba F, Nagano N, Yoshikawa K, Kayama K, Kobayashi A, Soeno Y, Numata O, Suenaga H, Imai K, Maruyama H, Fujinaga H, Furuya H, Ito Y; NON-INVASIVE PROCEDURE FOR PREMATURE NEONATES (NIPPN) STUDY GROUP. Uchiyama A, et al. Among authors: ito y. Pediatrics. 2020 Dec;146(6):e20201101. doi: 10.1542/peds.2020-1101. Pediatrics. 2020. PMID: 33214331 Clinical Trial.
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment.
Ohashi H, Watashi K, Saso W, Shionoya K, Iwanami S, Hirokawa T, Shirai T, Kanaya S, Ito Y, Kim KS, Nomura T, Suzuki T, Nishioka K, Ando S, Ejima K, Koizumi Y, Tanaka T, Aoki S, Kuramochi K, Suzuki T, Hashiguchi T, Maenaka K, Matano T, Muramatsu M, Saijo M, Aihara K, Iwami S, Takeda M, McKeating JA, Wakita T. Ohashi H, et al. Among authors: ito y. iScience. 2021 Apr 23;24(4):102367. doi: 10.1016/j.isci.2021.102367. Epub 2021 Mar 26. iScience. 2021. PMID: 33817567 Free PMC article.
CD4+ T cells are essential for the development of destructive thyroiditis induced by anti-PD-1 antibody in thyroglobulin-immunized mice.
Yasuda Y, Iwama S, Sugiyama D, Okuji T, Kobayashi T, Ito M, Okada N, Enomoto A, Ito S, Yan Y, Sugiyama M, Onoue T, Tsunekawa T, Ito Y, Takagi H, Hagiwara D, Goto M, Suga H, Banno R, Takahashi M, Nishikawa H, Arima H. Yasuda Y, et al. Among authors: ito y. Sci Transl Med. 2021 May 12;13(593):eabb7495. doi: 10.1126/scitranslmed.abb7495. Sci Transl Med. 2021. PMID: 33980577
10,559 results
You have reached the last available page of results. Please see the User Guide for more information.